Paloma Partners’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History
Bought
Maintained
Sold
Other funds holding SLXP
Paloma Partners's SLXP Position: Q2 2015 in Review
Paloma Partners sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 250,000 shares — an estimated $43.2M sold.
Paloma Partners first reported a position in SLXP in Q3 2014 and held it in 2 quarters. The position peaked at $43.2M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.
- Paloma Partners reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
- Paloma Partners sold 250,000 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $43.2M.
- Paloma Partners first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q3 2014 and held it in 2 quarters.
- Paloma Partners's SALIX PHARMACEUTICALS LTD DEL position peaked at $43.2M in Q1 2015.
- 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.
Based on Paloma Partners's 13F filing for Q2 2015, filed 14 Aug 2015.